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Abstract 
Background: Muntingia calabura (Elaecoparceae) is a medicinal plant traditionally used, 
particularly, by the Peruvian people to alleviate headache and cold, pain associated with 
gastric ulcers or to reduce the prostate gland swelling. Following the recent establishment of 
antinociceptive activity of M. calabura leaf, the present study was performed to further 
elucidate on the possible mechanisms of antinociception involved. Methods: The methanol 
extract of M. calabura (MEMC) was prepared in the doses of 100, 250 and 500 mg/kg. The 
role of bradykinin, protein kinase C, pottasium channels, and various opioid and non-opioid 
receptors in modulating the extract’s antinociceptive activity was determined using several 
antinociceptive assays. Results are presented as Mean ± standard error of mean (SEM). The 
one-way ANOVA test with Dunnett's multiple comparison was used to analyze and compare 
the data, with P < 0.05 as the limit of significance. Results: The MEMC, at all doses, 
demonstrated a significant (p < 0.05) dose-dependent antinociceptive activity in both the 
bradykinin- and phorbol 12-myristate 13-acetate (PMA)-induced nociception. Pretreatment of 
the 500 mg/kg MEMC with 10 mg/kg glibenclamide (an ATP-sensitive K+ channel 
inhibitor), the antagonist of μ-, δ- and κ-opioid receptors (namely 10 mg/kg β-funaltrexamine, 
1 mg/kg naltrindole and 1 mg/kg nor-binaltorphimine), and the non-opioid receptor 
antagonists (namely 3 mg/kg caffeine (a non-selective adenosinergic receptor antagonist), 
0.15 mg/kg yohimbine (an α2-noradrenergic antagonist), and 1 mg/kg pindolol (a β-
adrenoceptor antagonist)) significantly (p < 0.05) reversed the MEMC antinociception. 
However, 10 mg/kg atropine (a non-selective cholinergic receptor antagonist), 0.15 mg/kg 
prazosin (an α1-noradrenergic antagonist) and 20 mg/kg haloperidol (a non-selective 
dopaminergic antagonist) did not affect the extract's antinociception. The phytochemicals 
screening revealed the presence of saponins, flavonoids, tannins and triterpenes while the 
HPLC analysis showed the presence of flavonoid-based compounds. Conclusions: The 
antinociceptive activity of MEMC involved activation of the non-selective opioid 
(particularly the μ-, δ- and κ-opioid) and non-opioid (particularly adenosinergic, α2-
noradrenergic, and β-adrenergic) receptors, modulation of the ATP-sensitive K+ channel, and 
inhibition of bradikinin and protein kinase C actions. The discrepancies in MEMC 
antinociception could be due to the presence of various phytochemicals. 
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